Scinai Immunotherapeutics Ltd (SCNI) stock news · rev $1.3M
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
This SCNI news page leads with what Scinai Immunotherapeutics Ltd filed — not a scraped headline mill.
No cached 8-K sentence for SCNI yet. We will not pad this page with generic market recap.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SCNI stock page; for the tape open the quote page.
SCNI stock news FAQ
What are SCNI's latest revenue and net income?
Latest cached Scinai Immunotherapeutics Ltd (SCNI) revenue for Dec 31, 2025 was $1.3M. Net income was -$8.3M. Statements: https://lician.com/financials/scni
How did SCNI revenue change from the prior cached period?
Cached Scinai Immunotherapeutics Ltd (SCNI) revenue was up 99.2% from $658.0K (Dec 31, 2024) to $1.3M (Dec 31, 2025). Statements: https://lician.com/financials/scni
What is SCNI's market cap?
Scinai Immunotherapeutics Ltd (SCNI) market cap is $1.8M on the latest cached fundamentals snapshot.
What kind of company is SCNI?
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Where is SCNI stock news listed?
Cached stock news for Scinai Immunotherapeutics Ltd (SCNI) is listed at https://lician.com/news/scni. Filings: https://lician.com/sec/scni
Not investment advice.